🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an early phase I, single-arm, open-label clinical study designed to...
Status
Recruiting
Location
Biogenea Pharmaeuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07328087
Treatments Being Tested
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Effic...
Status
Enrolling By Invitation
Location
Precision NextGen Oncology & Research Center
Start Date
2022-11-30
Trial ID
NCT05741242
Treatments Being Tested
This phase I trial studies the safety of personalized neo-antigen peptide v...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2022-06-09
Trial ID
NCT05098210
Despite encouraging results of programmed cell death protein -1 (PD-1) immu...
Status
Unknown
Location
Netherlands Cancer Institute - Antoni van Leeuwenhoek
Start Date
2022-01
Trial ID
NCT04998474
Treatments Being Tested
The aim of this study is to evaluate the efficiency along with safety and t...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2020-12-23
Trial ID
NCT04688385
Treatments Being Tested
The purpose of this study is to determine if it is possible to make and saf...
Status
Withdrawn
Location
University of California, San Diego
Start Date
2024-06
Trial ID
NCT05153304
Treatments Being Tested
The aim of this project is to provide personalized multi-peptide vaccinatio...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT05014607
Treatments Being Tested
The purpose of this study is to test the safety, tolerability, and immunoge...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2016-04
Trial ID
NCT02721043
Treatments Being Tested
Microlyvaq™ is a first-line, non-randomized, two-arm clinical trial in adva...
Status
Enrolling By Invitation
Location
Biogenea Pharmaceuticals Ltd
Start Date
2026-02-02
Trial ID
NCT07285434
Treatments Being Tested
This proof of concept study is designed to test the safety and tolerability...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai (ISMMS)
Start Date
2022-01-05
Trial ID
NCT05010200